Adenoid Cystic Carcinoma patient tells her story
Adenoid Cystic Carcinoma (ACC) is a very rare salivary gland cancer and hard to treat that mainly affects females. Belinda Charlton-Gilfoyle told her story recently to Sunday magazine about the struggle to get a diagnosis for her persistent and excruciating facial pain.
Oracle are funding a four year PhD research project under the supervision of Dr Amanda Swain to understand ACC and discover new treatments to support patients like Belinda.
Read Belinda’s story here:
Oracle funded research into ACC
Oracle is proud to be funding an project at the Institute of Cancer Research looking into new therapeutic options for ACC.
We have also agreed to fund a second project taking place at Brunel University London, also focused on improving survival of patients with ACC. See New treatment options for Adenoid Cystic Carcinoma.
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break…
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice…
Mark Steele – Unforgettable evening of humour, resilience, and personal storytelling.
British comedian Mark Steele and military leader Major General Julian Buczacki are joining forces for an unforgettable evening of humour.
Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project
Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform…
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
12 Days of Christmas Winter Appeal 2024
Counting down 12 days of Christmas with fundraising ideas and keeping in touch with Oracle.
Petition to improve HPV Vaccine Uptake
Petition urges increase to HPV vaccine uptake and reduce preventable cancers caused by HPV.
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.